A Comparison of Body Fat Distribution in HIV-1 Infected Patients Receiving, Since the Beginning and for at Least Two Years, an Antiretroviral Therapy Based on Efavirenz or Lopinavir/Ritonavir Combined With Tenofovir + Emtricitabine or Lamivudine.
Phase of Trial: Phase IV
Latest Information Update: 07 Jan 2013
At a glance
- Drugs Efavirenz; Emtricitabine; Lamivudine; Lopinavir/ritonavir; Tenofovir disoproxil fumarate
- Indications HIV-1 infections
- Focus Adverse reactions
- Sponsors Abbott Laboratories
- 23 Feb 2012 Actual patient number (346) added as reported by ClinicalTrials.gov.
- 13 Oct 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 13 Oct 2011 Actual end date (Sep 2011) added as reported by ClinicalTrials.gov.